Lifestyle flexibility proves important for many users - peptides accommodate changing circumstances including pregnancy requiring treatment cessation, financial fluctuations allowing protocol modification rather than complete discontinuation, and evolving aesthetic preferences permitting gradual treatment reduction without dramatic appearance changes
one vial is not enough at the higher draw volume
Levels decrease as we age
However, N-terminal modifications, such as N-acetylation, D-norleucine substitution, or replacement with -aminobutyric acid (GABA), dramatically elongated the peptides half-lives
Both compounds are subcutaneous once-weekly
This may partly be attributed to the relatively small sample size, which could have limited the statistical power to detect significant differences in individual local manifestations between groups